Dual SGLT1/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice

• Author(s): Machado, Ubiratan Fabres
• Date: 2020
• Origin: Oasisbr
• Subject(s): HEPATOPATIAS
• Document Type: Journal article
• Language: English